Does CVS–Aetna Spell the End of Business as Usual?

The proposed $70 billion deal between CVS and Aetna would be a vertical merger that could heighten competition. By offering a new value proposition, the new company would aim to stay relevant despite encroachment by e-tailers and reduce total spending for care.

Bibliographic Details

Published in:	The New England journal of medicine Vol. 378; no. 7; pp. 593 - 595
Main Author:	Dafny, Leemore S
Format:	Journal Article
Language:	English
Published:	United States Massachusetts Medical Society 15.02.2018
Subjects:	Acquisitions & mergers Antitrust Drug stores Health care policy Market shares Pharmaceutical industry Pharmacy Prescription drugs Primary care
ISSN:	0028-4793, 1533-4406, 1533-4406
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!